CoChat

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Beyond the joints, TNFi (tumour necrosis factor inhibitor) therapy may confer systemic benefits in rheumatoid arthritis (RA). Several studies have investigated the role of TNFi on insulin resistance/sensitivity (IR/IS). This question is of general interest given the emerging evidence linking inflammation and insulin resistance. The main aim of this review was to summarise the published data and to determine the effects of TNFi on IR/IS. METHODS: We searched the PubMed and ISI Web of Knowledge databases for studies which examined the effects of TNFi on IR/IS. The studies were assessed independently by two reviewers according to a pre-specified protocol. The data on Homeostatic Model Assessment for Insulin resistance (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI) were pooled and reported as standard difference in means (SDM) with 95% confidence interval (CI) using a random-effects model. RESULTS: A total of eight studies with 260 subjects met the selection criteria. The duration of the studies was from 8 weeks to 12 months. There was statistically significant reduction in HOMA index in six out of eight studies and four reported significant increment in QUICKI. The pooled analysis revealed significant reduction in HOMA [SDM-0.148, 95%CI[-0.278 to -0.017], p=0.026] and increment in QUICKI [SDM 0.312, 95%CI[0.019 to 0.606], p=0.037] with TNFi. CONCLUSION: There is emerging evidence to support that TNFi therapy improves IS and reduces IR in RA. Further, well conducted trials are needed to determine if such effects translate to lower incidence of diabetes in RA or other autoimmune conditions on biologic therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0128889

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow chart of studies identification and selection.
Fig 1 Flow chart of studies identification and selection.CC BY · PubMed Central
Fig 2 Funnel plots (A) for HOMA from 8 selected studies and (B) for QUICKI from 4 selected studies evaluating effects of TNFi on IR/IS.
Fig 2 Funnel plots (A) for HOMA from 8 selected studies and (B) for QUICKI from 4 selected studies evaluating effects of TNFi on IR/IS.CC BY · PubMed Central
Fig 3 The Forest Plot for the effect of TNFi on HOMA index.
Fig 3 The Forest Plot for the effect of TNFi on HOMA index.CC BY · PubMed Central
Fig 4 The Forest Plot for the effect of TNFi on QUICKI.
Fig 4 The Forest Plot for the effect of TNFi on QUICKI.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 3

  1. FM Oguz, 2007, The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis, Acta Clin Belg, 62, 218, 10.1179/acb.2007.035 · DOI
  2. DN Kiortsis, 2005, Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis, Ann Rheum Dis, 64, 765, 10.1136/ard.2004.026534 · DOI · Paper page
  3. I Ferraz-Amaro, 2011, Systemic Blockade of TNF-α does not Improve Insulin Resistance in Humans, Horm Metab Res, 43, 801, 10.1055/s-0031-1287783 · DOI · Paper page

Cited by

See all 87

Metadata

Authors
Burska, A. N., Sakthiswary, R., & Sattar, N.
Affiliations
  • University of Leeds (GB)
  • University of Glasgow (GB)
Corresponding author
Sakthiswary, Rajalingham
Venue
PLOS ONE
Published
2015-06-25
Volume
10
Issue
6
Pages
e0128889
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1635013221
Cited by
84
References
40
Citations by year
2026: 5 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 14 · 2021: 12 · 2020: 10 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 7
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Greater South Information System
Funders
Universiti Kebangsaan Malaysia (DLP-2013-039)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
tumor necrosis factor inhibitors, rheumatoid arthritis, insulin resistance, insulin sensitivity, HOMA, QUICKI, diabetes risk
MeSH terms
Arthritis, Rheumatoid, Humans, Insulin Resistance, Tumor Necrosis Factor-alpha, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0128889
The paper
Burska, A. N., Sakthiswary, R., & Sattar, N. (2015). Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0128889

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.